<?xml version="1.0" encoding="utf-8" standalone="yes"?><rss version="2.0" xmlns:atom="http://www.w3.org/2005/Atom"><channel><title>NYS:LLY on 无关紧要的宇宙</title><link>https://316140221.github.io/Hugo/zh/tags/nyslly/</link><description>Recent content in NYS:LLY on 无关紧要的宇宙</description><generator>Hugo</generator><language>zh-CN</language><lastBuildDate>Tue, 29 Jul 2025 15:09:58 +0800</lastBuildDate><atom:link href="https://316140221.github.io/Hugo/zh/tags/nyslly/index.xml" rel="self" type="application/rss+xml"/><item><title>Novo Is to Lilly What LVMH Is to Hermes, Fund Manager Reckons</title><link>https://316140221.github.io/Hugo/zh/en/finance/2025-07-29-novo-is-to-lilly-what-lvmh-is-to-hermes-fund-manag/</link><pubDate>Tue, 29 Jul 2025 15:09:58 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/en/finance/2025-07-29-novo-is-to-lilly-what-lvmh-is-to-hermes-fund-manag/</guid><description>A widening gulf between the stock performances of Novo Nordisk A/S and its main competitor Eli Lilly &amp;amp; Co has drawn comparison with two of the world’s largest luxury-goods makers.</description></item><item><title>Novo Is to Lilly What LVMH Is to Hermes, Fund Manager Reckons</title><link>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-29-novo-is-to-lilly-what-lvmh-is-to-hermes-fund-manag/</link><pubDate>Tue, 29 Jul 2025 15:09:58 +0800</pubDate><guid>https://316140221.github.io/Hugo/zh/zh/finance/2025-07-29-novo-is-to-lilly-what-lvmh-is-to-hermes-fund-manag/</guid><description>A widening gulf between the stock performances of Novo Nordisk A/S and its main competitor Eli Lilly &amp;amp; Co has drawn comparison with two of the world’s largest luxury-goods makers.</description></item></channel></rss>